• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.14% Nasdaq Up0.41%

    OncoGenex Pharmaceuticals, Inc. (OGXI)

    -NasdaqCM
    2.10 Down 0.04(1.87%) 10:10AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Sep 30, 2014Jun 30, 2014Mar 31, 2014
    Total Revenue 5,653   4,803   4,929   11,731  
    Cost of Revenue -   -   -   -  
    Gross Profit 5,653   4,803   4,929   11,731  
    Operating Expenses
    Research Development9,852  9,586  9,883  16,903  
    Selling General and Administrative2,733  2,459  2,676  2,757  
    Non Recurring(267) -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (6,665) (7,242) (7,630) (7,929)
    Income from Continuing Operations
    Total Other Income/Expenses Net984  2,334  615  (707)
    Earnings Before Interest And Taxes(5,681)(4,908)(7,015)(8,636)
    Interest Expense -   -   -   -  
    Income Before Tax(5,681)(4,908)(7,015)(8,636)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(5,681)(4,908)(7,015)(8,636)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (5,681) (4,908) (7,015) (8,636)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (5,681) (4,908) (7,015) (8,636)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.